PT1575621E - Formulações de meios de contraste com tolerância biológica melhorada - Google Patents
Formulações de meios de contraste com tolerância biológica melhorada Download PDFInfo
- Publication number
- PT1575621E PT1575621E PT03786628T PT03786628T PT1575621E PT 1575621 E PT1575621 E PT 1575621E PT 03786628 T PT03786628 T PT 03786628T PT 03786628 T PT03786628 T PT 03786628T PT 1575621 E PT1575621 E PT 1575621E
- Authority
- PT
- Portugal
- Prior art keywords
- contrast media
- improved biological
- biological tolerance
- media formulations
- formulations
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 229940039231 contrast media Drugs 0.000 title abstract 2
- 239000002872 contrast media Substances 0.000 title abstract 2
- 150000001412 amines Chemical class 0.000 abstract 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43287902P | 2002-12-12 | 2002-12-12 | |
| US10/701,586 US7250153B2 (en) | 2002-12-12 | 2003-11-05 | Contrast media formulations having improved biological tolerance |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1575621E true PT1575621E (pt) | 2009-11-13 |
Family
ID=34107426
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT03786628T PT1575621E (pt) | 2002-12-12 | 2003-11-07 | Formulações de meios de contraste com tolerância biológica melhorada |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7250153B2 (enExample) |
| EP (1) | EP1575621B1 (enExample) |
| JP (1) | JP2006509841A (enExample) |
| KR (1) | KR101067159B1 (enExample) |
| CN (1) | CN1738651A (enExample) |
| AT (1) | ATE447416T1 (enExample) |
| AU (1) | AU2003295442B2 (enExample) |
| CA (1) | CA2509035C (enExample) |
| CY (1) | CY1110105T1 (enExample) |
| DE (1) | DE60329939D1 (enExample) |
| DK (1) | DK1575621T3 (enExample) |
| ES (1) | ES2333863T3 (enExample) |
| IL (1) | IL169119A (enExample) |
| NO (1) | NO332350B1 (enExample) |
| NZ (1) | NZ541139A (enExample) |
| PT (1) | PT1575621E (enExample) |
| SI (1) | SI1575621T1 (enExample) |
| WO (1) | WO2004054637A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20070015517A (ko) * | 2004-03-11 | 2007-02-05 | 말린크로트, 인코포레이티드 | 요오드화된 단량체 및 이량체의 혼합물을 포함하는 ｘ-선조영제 제형 |
| FR2899581B1 (fr) * | 2006-04-07 | 2008-06-27 | Guerbet Sa | Procede d'atomisation du ioxilan |
| WO2009091758A1 (en) | 2008-01-14 | 2009-07-23 | Mallinckrodt Inc. | Process for the preparation of iosimenol |
| RU2012138280A (ru) * | 2010-03-23 | 2014-04-27 | ДжиИ Хелткер АС | Получение стабилизированной диагностической композиции для рентгеновского исследования |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR222337A1 (es) * | 1978-07-04 | 1981-05-15 | Nyegaard & Co As | Procedimiento para preparar una solucion esteril inyectable fisiologicamente aceptable de un agente de contraste de rayos x |
| US5698739A (en) * | 1989-07-05 | 1997-12-16 | Schering Aktiengesellschaft | Carboxamide non-ionic contrast media |
| KR19990022943A (ko) * | 1995-06-16 | 1999-03-25 | 밀로스 소박 | 비이온성 조영제로서의 포르밀 유도체 |
| DE19648650C2 (de) | 1996-01-29 | 1998-07-02 | Schering Ag | Puffersysteme und deren Verwendung zur Stabilisierung pharmazeutischer Zubereitung |
-
2003
- 2003-11-05 US US10/701,586 patent/US7250153B2/en not_active Expired - Lifetime
- 2003-11-07 EP EP03786628A patent/EP1575621B1/en not_active Expired - Lifetime
- 2003-11-07 WO PCT/US2003/035762 patent/WO2004054637A2/en not_active Ceased
- 2003-11-07 DE DE60329939T patent/DE60329939D1/de not_active Expired - Lifetime
- 2003-11-07 NZ NZ541139A patent/NZ541139A/en not_active IP Right Cessation
- 2003-11-07 SI SI200331689T patent/SI1575621T1/sl unknown
- 2003-11-07 KR KR1020057010571A patent/KR101067159B1/ko not_active Expired - Fee Related
- 2003-11-07 AU AU2003295442A patent/AU2003295442B2/en not_active Ceased
- 2003-11-07 CA CA2509035A patent/CA2509035C/en not_active Expired - Lifetime
- 2003-11-07 ES ES03786628T patent/ES2333863T3/es not_active Expired - Lifetime
- 2003-11-07 CN CNA2003801090166A patent/CN1738651A/zh active Pending
- 2003-11-07 PT PT03786628T patent/PT1575621E/pt unknown
- 2003-11-07 AT AT03786628T patent/ATE447416T1/de active
- 2003-11-07 DK DK03786628T patent/DK1575621T3/da active
- 2003-11-07 JP JP2005508300A patent/JP2006509841A/ja not_active Abandoned
-
2005
- 2005-06-09 IL IL169119A patent/IL169119A/en active IP Right Grant
- 2005-07-08 NO NO20053343A patent/NO332350B1/no not_active IP Right Cessation
-
2010
- 2010-02-01 CY CY20101100092T patent/CY1110105T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI1575621T1 (sl) | 2010-01-29 |
| CY1110105T1 (el) | 2015-01-14 |
| US20050025711A1 (en) | 2005-02-03 |
| NO20053343D0 (no) | 2005-07-08 |
| AU2003295442A1 (en) | 2004-07-09 |
| NO20053343L (no) | 2005-09-08 |
| WO2004054637A3 (en) | 2004-09-16 |
| CA2509035C (en) | 2011-07-19 |
| WO2004054637A2 (en) | 2004-07-01 |
| US7250153B2 (en) | 2007-07-31 |
| IL169119A0 (en) | 2007-07-04 |
| CN1738651A (zh) | 2006-02-22 |
| CA2509035A1 (en) | 2004-07-01 |
| EP1575621B1 (en) | 2009-11-04 |
| EP1575621A4 (en) | 2008-11-26 |
| KR20050088312A (ko) | 2005-09-05 |
| ATE447416T1 (de) | 2009-11-15 |
| DE60329939D1 (de) | 2009-12-17 |
| KR101067159B1 (ko) | 2011-09-22 |
| ES2333863T3 (es) | 2010-03-02 |
| NO332350B1 (no) | 2012-09-03 |
| EP1575621A2 (en) | 2005-09-21 |
| JP2006509841A (ja) | 2006-03-23 |
| DK1575621T3 (da) | 2009-12-14 |
| AU2003295442B2 (en) | 2008-11-06 |
| IL169119A (en) | 2010-06-16 |
| NZ541139A (en) | 2008-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA04008068A (es) | Metodo para administrar moleculas de glp-1. | |
| WO2003061593A3 (en) | Novel targeted compositions for diagnostic and therapeutic use | |
| DK1472344T3 (da) | Bakteriofaglysin | |
| ECSP077401A (es) | Medicamentos que contienen compuestos de carbonilo y su uso | |
| WO2007039858A3 (en) | Targeted imaging and/or therapy using the [3+2] azide-alkyne cycloaddition | |
| WO2004064595A3 (en) | Multivalent constructs for therapeutic and diagnostic applications | |
| MY135222A (en) | Substituted phenylacetamides and their use as glucokinase activators | |
| PL372146A1 (en) | Orally administrable composition for the photoprotection of the skin | |
| WO2004073623A3 (en) | Treatment of conditions associated with decreased nitric oxide bioavailability, including elevated arginase conditions | |
| EP1479342A3 (en) | Mental state assessment apparatus and mental state assessment method | |
| IT1319258B1 (it) | Catalizzatore per la idrodeclorurazione del tetracloruro di carbonio acloroformio. | |
| WO2004002803A3 (de) | Runge | |
| WO2003078574A3 (en) | Novel metabolic targets and markers | |
| CY1110105T1 (el) | Σκευασματα σκιαγραφικων μεσων που εχουν βελτιωμενη ανεκτικοτητα | |
| DE602007014249D1 (en) | Lung | |
| TW200604149A (en) | Norbornane based cycloaliphatic compounds containing nitrile groups | |
| TW200732417A (en) | Composition containing polylactic acid | |
| EP1281887A3 (de) | Rundlager | |
| ITMI20031382A1 (it) | Sistema di disinnesto per l'azionamento di una frizione e procedimento per il montaggio di un sistema di disinnesto. | |
| WO2006071949A3 (en) | Zebrafish heterotrimer g-protein gamma 2 subunit (gng2) | |
| GB0322750D0 (en) | Organic compounds | |
| WO2006034392A3 (en) | Therapeutic quinones | |
| Covell | The Study of Japanese Buddhist Culture Topics for Consideration | |
| GT200300260A (es) | Derivados de anilinopirazol utiles en el tratamiento de la diabetes | |
| TH87788A (th) | สูตรยาที่มีการปล่อยคงที่และการใช้ของสิ่งนั้น |